Data Bridge Market Research analyses that the restriction endonucleases products market which was USD 375.29 million in 2022, is expected to reach USD 598.16 million by 2030, at a CAGR of 6.00% during the forecast period 2023 to 2030.
Read MoreThe global Lysosomal Function Enhancing Drug market size was valued at USD 964.00 Million in 2025and is expected to reach USD 4285.22 Million by 2033, at a CAGR of 20.50% during the forecast period
Read MoreThe global electroencephalography devices market size was valued at USD 1.30 billion in 2024 and is expected to reach USD 1.97 billion by 2032, at a CAGR of 5.40% during the forecast period.
Read MoreThe global epigenetic reader protein inhibitor market size was valued at USD 936.00 billion in 2025 and is expected to reach USD 3971.27 billion by 2033, at a CAGR of 19.80% during the forecast period
Read MoreThe global urea breath test market size was valued at USD 129.98 Million in 2024 and is expected to reach USD 199.48 Million by 2032, at a CAGR of 5.50% during the forecast period.
Read More